Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Theoretical Biology & Medical Modelling|July 24, 2014
Optimal back-extrapolation method for estimating plasma volume in humans using the indocyanine green dilution methodDavid Polidori, Clarence Rowley
Clinical Pharmacokinetics|June 5, 2015
Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 InhibitorDamayanthi Devineni, David Polidori
Diabetologia|March 4, 2014
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetesDavid Polidori, Andrea Mari, Ele Ferrannini
Diabetes/Metabolism Research and Reviews|October 10, 2013
Impaired decline in renal threshold for glucose during pregnancy - a possible novel mechanism for gestational diabetes mellitusPinchas Klein, David Polidori, Orit Twito, et al.
Diabetes Care|November 26, 2015
Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to BedsideSunder Mudaliar, David Polidori, Brian Zambrowicz, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2014
Single- and multiple-dose pharmacokinetics and pharmacodynamics of canagliflozin, a selective inhibitor of sodium glucose co-transporter 2, in healthy participantsDamayanthi Devineni, Nicole Vaccaro, David Polidori, et al.
Clinical Therapeutics|April 15, 2014
Effects of hydrochlorothiazide on the pharmacokinetics, pharmacodynamics, and tolerability of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participantsDamayanthi Devineni, Nicole Vaccaro, David Polidori, et al.
Obesity (Silver Spring, Md.)|November 3, 2016
How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy IntakeDavid Polidori, Arjun Sanghvi, Randy J Seeley, et al.
Pediatric Diabetes|December 23, 2017
Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetesWilliam V Tamborlane, David Polidori, Domenick Argenti, et al.
Diabetes Care|October 22, 2015
Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 DiabetesRobert R Henry, Payal Thakkar, Cindy Tong, et al.
Pageof 5